Patents-Review.com
ClassID:

94713 ⎘

C07D267/12 - CPC Classification

Classification description:

Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms; Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems

Sub-classes:
Recent Application in this class:
#1
20250179004
2025-06-05

PROCESSES AND INTERMEDIATES FOR PREPARING MCL1 INHIBITORS

 #2
20220363651
2022-11-17

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #3
20220204461
2022-06-30

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #4
20220177409
2022-06-09

Processes and intermediates for preparing MCL1 inhibitors

 #5
20210009540
2021-01-14

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #6
20210009539
2021-01-14

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #7
20210009538
2021-01-14

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #8
20200055830
2020-02-20

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #9
20200048212
2020-02-13

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #10
20200048211
2020-02-13

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #11
20200002298
2020-01-02

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #12
20190127339
2019-05-02

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #13
20190119235
2019-04-25

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #14
20190119234
2019-04-25

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #15
20190119233
2019-04-25

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #16
20190119232
2019-04-25

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #17
20190119231
2019-04-25

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #18
20190119230
2019-04-25

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #19
20190119229
2019-04-25

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #20
20190119228
2019-04-25

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #21
20190119227
2019-04-25

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #22
20190112284
2019-04-18

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #23
20190112283
2019-04-18

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #24
20190112282
2019-04-18

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #25
20190112281
2019-04-18

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #26
20190112280
2019-04-18

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #27
20190112279
2019-04-18

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #28
20190062288
2019-02-28

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #29
20190016693
2019-01-17

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #30
20190016692
2019-01-17

3-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #31
20160222028
2016-08-04

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #32
20160222022
2016-08-04

3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #33
20160221973
2016-08-04

3-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #34
20160221972
2016-08-04

3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

 #35
20150361059
2015-12-17

Substituted hetero-azepinones

 #36
20150203442
2015-07-23

Anthraquinone analogs and methods of making and using thereof

 #37
20100105657
2010-04-29

Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease